Concepedia

Ronnatrai Rueangweerayut

RR

Statistics

Publications

13

Citations

1.1K

H-Index

12

Active since

2011

Affiliations

Maesot General Hospital(Current)

Medicines for Malaria Venture

Mahidol Oxford Tropical Medicine Research Unit

Mahidol University

GlaxoSmithKline (United Kingdom)

Ronnatrai Rueangweerayut is an author at Maesot General Hospital specializing in malaria, pharmacology, and clinical pharmacology.

Publications per year

2011–2017

13

Publications

13

Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study

Alejandro Llanos‐Cuentas, Marcus Lacerda, Ronnatrai Rueangweerayut et al. · The Lancet · 2013 · 245 citations

, , +14

Spiroindolone KAE609 for Falciparum and Vivax Malaria

Nicholas J. White, Sasithon Pukrittayakamee, Aung Pyae Phyo et al. · New England Journal of Medicine · 2014 · 244 citations · Full text

, , +17

Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers

Ronnatrai Rueangweerayut, Germana Bancone, Emma J. Harrell et al. · American Journal of Tropical Medicine and Hygiene · 2017 · 119 citations · Full text

, , +13

Pyronaridine–Artesunate versus Mefloquine plus Artesunate for Malaria

Ronnatrai Rueangweerayut, Aung Pyae Phyo, Chirapong Uthaisin et al. · New England Journal of Medicine · 2012 · 110 citations · Full text

, , +16

Pyronaridine-Artesunate versus Chloroquine in Patients with Acute Plasmodium vivax Malaria: A Randomized, Double-Blind, Non-Inferiority Trial

Poravuth Yi, Duong Socheat, Ronnatrai Rueangweerayut et al. · PLoS ONE · 2011 · 108 citations · Full text

, , +14

1–5 of 13